The Wilds of Biotech: A Shift in Focus for BioStem Technologies BioStem Technologies has undergone a significant transformation, as evident from its recent Q1 earnings call.
The company has shifted its focus towards the hospital market, departing from its previous emphasis on physician offices.
This strategic shift was triggered by an acquisition that brought with it expanded perinatal tissue allografts, an experienced sales team, and a range of hospital customers.